Loading organizations...
Loading organizations...
Biotechnology company developing treatment for peanut allergy.
Aravax has raised $42.0M across 1 funding round.
Aravax has raised $42.0M in total across 1 funding round.
Aravax has raised $42.0M in total across 1 funding round.
Aravax's investors include Agati Capital, Brandon Capital, Grant Dooley, Novartis, Tenmile, Uniseed.
Aravax has raised $42.0M across 1 funding round. Most recently, it raised $42.0M Series B in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 23, 2024 | $42.0M Series B | Agati Capital, Brandon Capital, Grant Dooley, Novartis, Tenmile, Uniseed |